Sino-German trade barriers "must be dismantled" to benefit of medtech
This article was originally published in Clinica
Executive Summary
German medtech industry association Spectaris has demanded that trade barriers with China be broken down. "German interest in the Chinese medtech market is enormous," said the association's deputy chairman, Michael Koller. But for smooth bilateral relations to be maintained, outstanding environmental law issues and product approval sticking-points must be addressed, he told the Deutsch-Chinesische Dialogforum on industrial and technological co-operation, in Berlin. Chinese Premier Wen Jiabao was present at the meeting to hear Mr Koller ask for China to exclude medtech products from its national law on banning certain dangerous substances, and thereby adopt the European-style approach on this issue. He also asked for China to become more involved in the GHTF process, noting the potential benefits of mutual recognition of trials. Germany exports medtech products valued at €500m ($648m) to China and imports some €340m-worth.
You may also be interested in...
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.
A Healthtech Global Software Business With A Silicon Valley Look
Royal Philips’ head of Enterprise Informatics Shez Partovi explains the rationale behind the 2023 decision to set up a vertical business for digital, AI and software applications, to operate alongside imaging, monitoring and interventional therapy.